Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells
Kazim H. Narsinh, … , Robert C. Robbins, Joseph C. Wu
Kazim H. Narsinh, … , Robert C. Robbins, Joseph C. Wu
Published February 7, 2011
Citation Information: J Clin Invest. 2011;121(3):1217-1221. https://doi.org/10.1172/JCI44635.
View: Text | PDF
Brief Report Stem cells

Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells

  • Text
  • PDF
Abstract

Human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) are promising candidate cell sources for regenerative medicine. However, despite the common ability of hiPSCs and hESCs to differentiate into all 3 germ layers, their functional equivalence at the single cell level remains to be demonstrated. Moreover, single cell heterogeneity amongst stem cell populations may underlie important cell fate decisions. Here, we used single cell analysis to resolve the gene expression profiles of 362 hiPSCs and hESCs for an array of 42 genes that characterize the pluripotent and differentiated states. Comparison between single hESCs and single hiPSCs revealed markedly more heterogeneity in gene expression levels in the hiPSCs, suggesting that hiPSCs occupy an alternate, less stable pluripotent state. hiPSCs also displayed slower growth kinetics and impaired directed differentiation as compared with hESCs. Our results suggest that caution should be exercised before assuming that hiPSCs occupy a pluripotent state equivalent to that of hESCs, particularly when producing differentiated cells for regenerative medicine aims.

Authors

Kazim H. Narsinh, Ning Sun, Veronica Sanchez-Freire, Andrew S. Lee, Patricia Almeida, Shijun Hu, Taha Jan, Kitchener D. Wilson, Denise Leong, Jarrett Rosenberg, Mylene Yao, Robert C. Robbins, Joseph C. Wu

×

Figure 3

Limited growth and differentiation potential of hiPSC-derived cells.

Options: View larger image (or click on image) Download as PowerPoint
Limited growth and differentiation potential of hiPSC-derived cells.
(A)...
(A) Representative bioluminescence images of immunocompromised SCID beige mice implanted with 106 hESCs or 106 hiPSCs stably expressing firefly luciferase reporter construct. (B) Quantitative analysis of bioluminescence imaging data shows slower teratoma growth kinetics of hiPSC-derived teratomas (mean ± SEM for n = 10). sr, steradian. (C) Immunostaining for cardiac troponin T (cTnT) of hESC- and hiPSC-derived cardiomyocytes (original magnification, ×20). (D) Assessment of the percentage of cell aggregates containing beating cardiomyocytes after 14 days shows substantial variation in the yield of hiPSC-CMs, while the yield of hESC-CMs is stable (mean ± SEM for n = 8). (E) Immunostaining for CD31 (left) and CD144 (top right) EC markers and robust LDL uptake (bottom right) for hESC-derived ECs after 14 days of differentiation before (bottom left) and after (top left and top right) FACS enrichment (original magnification, ×20). (F) Cell proliferation and CD31 expression over 2–3 weeks after isolation of EC populations show limited stability and proliferative capacity of hiPSC-ECs in comparison with hESC-ECs (mean ± SD for n = 4).
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts